Rituxan Approved for Rheumatoid Arthritis - The Facts of Rituxan

Rituxan, the world's best-selling cancer drug, has been FDA-approved to treat rheumatoid arthritis patients. Rituxan is to be used in combination with methotrexate to treat rheumatoid arthritis by reducing the signs and symptoms in adult patients who have moderately-to-severely active rheumatoid arthritis and have failed one or more anti-TNF drugs (Enbrel, Remicade, Humira).

Rituxan received a priority review from the FDA and the decision was long-awaited and anticipated. Learn more about Rituxan. How is it administered? How much does it cost? How does it differ from other biologics? Read The Facts Of Rituxan.

• Rheumatoid Arthritis Screening Quiz
• Rheumatoid Arthritis: Test Your Knowledge
• Rheumatoid 101: Free E-Course Newsletter
• Biologic Response Modifier:- What Is It?
• TNF Blockers: Test Your Knowledge